Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...

Arcutis Biotherapeutics recently announced that the FDA has accepted its supplemental New Drug Application for ZORYVE cream 0.3% to treat plaque psoriasis in children aged 2 to 5 years, with a PDUFA ...

The NHS suggests speaking to a pharmacist if you've tried to get rid of it and things are not working, especially if the ...

Psoriasis can affect the fingers, knuckles, nails, palms, and soles. Here’s what this psoriasis looks like and how to relieve symptoms like itch.

The company continues to receive good news from the Food and Drug Administration.

Psoriasis is a chronic skin condition which normally gives rise to raised, red, and scaly patches of skin, often on the knees, elbows, scalp and behind the ears. The condition seems to be linked to ...

The sNDA was supported by data from a 4 week MUSE study and a long-term open-label study in children aged 2 to 5 years.

Biologic therapy use among patients with psoriatic disease was associated with a lower risk for malignancy compared with topical therapy use.

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical ...

Home remedies can sometimes soothe scalp psoriasis, an autoimmune, inflammatory condition marked by itching, irritation, and flaky, scaly skin. Still, research on the safety and effectiveness of home ...

If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2, offering patients and caregivers an important alternative to ...